Transforming growth factor-β and Th17 responses in resistance to primary murine schistosomiasis mansoni

Cytokine

Volumn 48, Issue 3, 2009, Pages 239-245

  Tallima, Hatem ^a,b   Salah, Mohamed ^c   Guirguis, Fatem R ^c   El Ridi, Rashika ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b AMERICAN UNIVERSITY IN CAIRO   (Egypt)

^c THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

Cytokine response; IL 17; Murine primary schistosomiasis; Schistosoma mansoni; TGF

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; MONOCLONAL ANTIBODY; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOPOTENTIATION; INFECTION RESISTANCE; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOUSE STRAIN; NONHUMAN; PARASITE IDENTIFICATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SCHISTOSOMULUM; TH1 CELL; TH17 CELL; TH2 CELL; VACCINATION; WORM EGG; WORM INFECTION;

ANIMALS; ANTIBODIES, HELMINTH; CELL LINEAGE; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA, MESSENGER; SCHISTOSOMIASIS MANSONI; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFORMING GROWTH FACTOR BETA;

MURINAE; MUS; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 70350007738     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.07.581     Document Type: Article

References (52)

1. McManus D.P., and Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21 (2008) 225-242
2. Siddiqui A.A., Ahmad G., Damian R.T., and Kennedy R.C. Experimental vaccines in animal models for schistosomiasis. Parasitol Res 102 (2008) 825-833
3. Coulson P.S. The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine?. Adv Parasitol 39 (1997) 271-336
4. Wynn T.A., and Hoffmann K.F. Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2?. Parasitol Today 16 (2000) 497-501
5. Hewitson J.P., Hamblin P.A., and Mountford A.P. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol 27 (2005) 271-280
6. Anthony R.M., Rutitzky L.I., Urban Jr. J.F., Stadecker Jr. M., and Gause W.C. Protective immune mechanisms in helminth infection. Nat Rev Immunol 7 (2007) 975-987
7. Mangold B.L., and Dean D.A. Autoradiographic analysis of Schistosoma mansoni migration from skin to lungs in naïve mice. Evidence that most attrition occurs after the skin phase. Am J Trop Med Hyg 32 (1983) 785-789
8. Wilson R.A., Coulson P.S., and Dixon B. Migration of the schistosomula of Schistosoma mansoni in mice vaccinated with radiation-attenuated cercariae and normal mice: an attempt to identify the timing and site of parasite death. Parasitology 92 (1986) 101-106
9. Dean D.A., and Mangold B.L. Evidence that both normal and immune elimination of Schistosoma mansoni take place at the lung stage of migration prior to parasite death. Am J Trop Med Hyg 47 (1992) 238-248
10. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
11. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
12. Harrington L.E., Mangan P.R., and Weaver C.T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18 (2006) 349-356
13. Bi Y., Liu G., and Yang R. Th17 cell induction and immune regulatory effects. J Cell Physiol 211 (2007) 273-278
14. H17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8 (2008) 337-348
15. McGeachy M.J., and Cua D.J. Th17 cell differentiation: the long and winding road. Immunity 28 (2008) 445-453
16. Zheng W., and Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89 (1997) 587-596
17. Ouyang W., Ranganath S.H., Weindel K., Bhattacharya D., Murphy T.L., Sha W.C., et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9 (1998) 745-755
18. Murphy K.M., and Reiner S.L. The lineage decisions of helper T cells. Nat Rev Immunol 2 (2002) 933-944
19. Berenson L.S., Ota N., and Murphy K.M. Issues in T-helper 1 development-resolved and unresolved. Immunol Rev 202 (2004) 157-174
20. Park I.K., Shultz L.D., Letterio J.J., and Gorham J.D. TGF-β1 inhibits T-bet induction by IFN-γ in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1. J Immunol 175 (2005) 5666-5674
21. H-17 cell-mediated pathology. Nat Immunol 8 (2007) 1390-1397
22. Matsuzaki G., and Umemura M. Interleukin-17 as an effector molecule of innate and adaptive immunity against infections. Microbiol Immunol 51 (2007) 1139-1147
23. H17 lineage. Nature 441 (2006) 231-234
24. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
25. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., and Flavell R.A. Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24 (2006) 99-146
26. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 6 (1990) 597-674
27. Krakauer T., Vilcek J., and Oppenheim J.J. Proinflammatory cytokines TNF and IL-1 families, chemokines, TGF-β, and others. In: Paul W.E. (Ed). Fundamental immunology (1999), Lippincott-Raven, Philadelphia 775-811
28. Smithers S.R., and Terry R.J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55 (1965) 695-700
29. El Ridi R., Salem R., Wagih A., Mahana N., El Demellawy M., and Tallima H. Influence of interleukin-2 and interferon-gamma in murine schistosomiasis. Cytokine 33 (2006) 281-288
30. El Ridi R., and Tallima H. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. Vaccine 27 (2009) 666-673
31. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
32. Overbergh L., Valckx D., Waer M., and Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11 (1999) 305-312
33. Overbergh L., Giulietti A., Valckx D., Decallonne B., Bouillon R., and Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14 (2003) 33-43
34. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37 (2007) 2695-2706
35. Wu Q., Martin R.J., Rino J.G., Breed R., Torres R.M., and Chu H.W. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 9 (2007) 78-86
36. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
37. Cheever A.W. Relative resistance of the eggs of human schistosomes to digestion in potassium hydroxide. Bull World Health Organ 43 (1970) 601-603
38. Da'dara A.A., Skelly P.J., Wang M.M., and Harn D.A. Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 20 (2001) 359-369
39. Da'dara A.A., Skelly P.J., Walker M.C., and Harn D.A. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection. Parasite Immunol 25 (2003) 429-437
40. Fonseca C.T., Brito C.F.A., Alves J.B., and Oliveira S.C. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-γ and TNF-α dependent pathway. Vaccine 22 (2004) 503-510
41. Garcia T.C.M., Fonseca C.T., Pacifico L.G.G., do Valle Duraes F., Marinho F.A.V., Penido M.L.O., et al. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice. Acta Trop 106 (2008) 162-167
42. El Ridi R., Montash M., and Tallima H. Immunogenicity and vaccine potential of di-peptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. Scand J Immunol 60 (2004) 392-402
43. Infante-Duarte C., and Kamradt T. Th1/Th2 balance in infection. Springer Semin Immunopathol 21 (1999) 317-338
44. Infante-Duarte C., Horton H.F., Byrne M.C., and Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165 (2000) 6107-6115
45. Khader S.A., Pearl J.E., Sakamoto K., Gilmartin L., Bell G.K., Jelley-Gibbs D.M., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J Immunol 175 (2005) 788-795
46. Cruz A., Khader S.A., Torrado E., Fraga A., Pearl J.E., Pedrosa J., et al. Cutting edge: IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 177 (2006) 1416-1420
47. Laan M., Cui Z.H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162 (1999) 2347-2352
48. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette - Guerin infection. J Immunol 178 (2007) 3786-3796
49. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194 (2001) 519-527
50. Huang W., Na L., Fidel P.L., and Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190 (2004) 624-631
51. Amsen D., Antov A., and Flavell R.A. The different faces of Notch in T-helper-cell differentiation. Nat Rev Immunol 9 (2009) 116-124
52. Phelan J.D., Orekov T., and Finkelman F.D. Cutting edge: mechanism of enhancement of in vivo cytokine effects by anti-cytokine monoclonal antibodies. J Immunol 180 (2008) 44-48